Expert Q&As
Launching in EU - Q&A 4
What additional national regulatory requirements must we navigate after EMA approval?
Access decades of experience
What’s Inside the Q&A:
National Requirements
EMA approval is just the beginning. Critical country-specific steps including packaging and national license numbers.
Quality Person and Batch Release
Mandatory QP certification for every batch. How to establish EU import licenses and testing processes.
Serialization and Safety Compliance
EU Falsified Medicines Directive requirements for unique identifiers. Setting up connections to European verification systems.
Local PV and Compliance
Post-launch pharmacovigilance obligations. Ongoing compliance requirements and inspection readiness.
Download our expert answer
Discover our latest news
Expert Q&As
Launching in EU - Q&A 3
How to choose the right location for our European headquarters or hub?
Expert Q&As
First interactions with EMA - Q&A 1
What are the different regulatory pathways available when expanding to Europe and which one is the best fit for me?
Expert Q&As
Launching in EU - Q&A 1
Why is launching a drug in Europe different from launching in the US?
